SZodixStudyAcademic Library

Shelves Open access

Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated

Drug Prices and Value for Money · Study

ArticleShelves

ArticleDrug Prices and Value for Money

David A Henry2005

Article2005

Drug Prices and Value for Money

David A Henry · Suzanne Rose Hill · Anthony Harris

115 citations·0/0 files stored·JAMA

No readable copy stored yet — this record is metadata only.

No open-access location is known for this record yet.

Literature note Cite in a project Citation map

Pharmaceutical Economics and Policy Healthcare Policy and Management Health Systems, Economic Evaluations, Quality of Life

Abstract

No abstract was published for this record.

Paper brief

Loading…

Cite this work

Citation unavailable for this work.

BibTeX RIS CSL-JSON

No public copy is stored for this record, so only the metadata is cited.

Citations in this library

Citation map →

Stored only when both papers are in the corpus — 115 citations exist upstream.

References

2000Problems With the Interpretation of Pharmacoeconomic Analyses 2004The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 2005Quality, Innovation, and Value for Money

Cited by

2013Value in Pharmaceutical Pricing 2007Measuring Preferences for Cost-Utility Analysis 2012Preferences for cancer treatments: an overview of methods and applications in oncology 2008The Role of Economic Evidence in Canadian Oncology Reimbursement Decision-Making: To Lambda and Beyond 2018Cost-Utility Analysis of Home-Based Telerehabilitation Compared With Centre-Based Rehabilitation in Patients With Heart Failure 2022An overview of Fintech applications to solve the puzzle of health care funding: state-of-the-art in medical crowdfunding

Related works

Explore the map →

Papers that cite the same references — the relational fallback while embeddings are still backfilling.

2008The Role of Economic Evidence in Canadian Oncology Reimbursement Decision-Making: To Lambda and Beyondarticle · 2 shared references 2008The use of cost-effectiveness by the National Institute for Health and Clinical Excellence (NICE): no(t yet an) exemplar of a deliberative processreview · 2 shared references 2008The Role of Value for Money in Public Insurance Coverage Decisions for Drugs in Australia: A Retrospective Analysis 1994-2004article · 1 shared reference 2005Common Methodological Flaws in Economic Evaluationsreview · 1 shared reference 2004Inclusion of cost effectiveness in licensing requirements of new drugs: the fourth hurdlearticle · 1 shared reference 2004HTA 101 INTRODUCTION TO HEALTH TECHNOLOGY ASSESSMENTarticle · 1 shared reference

Details

Year2005

Typearticle

Published2005-11-22

VenueJAMA

ISSN-L0002-9955

Languageen

Citations115

Files0 public / 0

ShelfPharmaceutical Economics and Policy

Identifiers

doi10.1001/jama.294.20.2630

openalex_workW2156900441

Links

Imported from OpenAlex (CC0) — nothing here is generated.